HS
MJN

HighVista Strategies’s Mead Johnson Nutrition Company MJN Stock Holding History

HighVista Strategies’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-165,974
Closed -$14.8M – 258
2017
Q1 		$14.8M Buy
+165,974
New +$13.6M 3.31% 8

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

HighVista Strategies's MJN Position: Q2 2017 in Review

HighVista Strategies sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 165,974 shares — an estimated $14.8M sold.

HighVista Strategies first reported a position in MJN in Q1 2017 and held it in 1 quarter. The position peaked at $14.8M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • HighVista Strategies reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • HighVista Strategies sold 165,974 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $14.8M.
  • HighVista Strategies first reported a position in Mead Johnson Nutrition Company in Q1 2017 and held it in 1 quarter.
  • HighVista Strategies's Mead Johnson Nutrition Company position peaked at $14.8M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on HighVista Strategies's 13F filing for Q2 2017, filed 14 Aug 2017.